Actionable news
0
All posts from Actionable news
Actionable news in GLMD: GALMED PHARMACEUTICALS Ltd.,

Gilead Buy Could Bolster Galmed Valuation

Gilead announced an agreement with privately held Nimbus Therapeutics to acquire the company’s Acetyl-CoA Carboxylase, or ACC, inhibitor program.

The program includes a lead candidate, NDI-010976...


More